Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
10000 participants
OBSERVATIONAL
2007-07-31
2033-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Late-lumen Changes After Drug-Coated Balloon Angioplasty Versus Drug-Eluting Stents in De Novo Coronary Lesions
NCT06954714
Fractional Flow Reserve Versus Angiography for Treatment-Decision and Evaluation of Significant Left MAIN Coronary Artery Disease
NCT05829889
ANGiographic Evaluation of Left Main Coronary Artery INtErvention
NCT04604197
Chronic Total Occlusion Registry
NCT04041921
The Clinical Course of Coronary Artery Disease in Coronary Multidetector Computed Tomographic Angiogram
NCT01142973
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Left Main disease
Consecutive patients with unprotected LMCA diseases at participating centers will be evaluated for the entry into the study.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* The LMCA is considered unprotected if there are no patent coronary artery bypass grafts to the left anterior descending artery or the left circumflex artery.
* No limitation of clinical or lesion characteristics
* Age \>18 years
* The patient or guardian agrees to the study protocol and the schedule of clinical follow-up, and provides informed, written consent, as approved by the appropriate Institutional Review Board/Ethics Committee of the respective clinical site.
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
CardioVascular Research Foundation, Korea
OTHER
Seung-Jung Park
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Seung-Jung Park
MD,PhD, Chairman,Heart Institute, Asan Medical Center,University of Ulsan,College of Medicine
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Seung-Jung Park, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
CVRF
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Zhongshan Hospital
Shanghai, , China
Sarawak General Hospital
Kuching, , Malaysia
Hallym University medical center
Anyang, , South Korea
Soonchunhyang University Hospital, Buchen
Bucheon-si, , South Korea
The Catholic University of Korea, Bucheon ST.Mary's Hospital
Bucheon-si, , South Korea
Inje University Busan Paik Hospital
Busan, , South Korea
Soonchunhyang University Hospital, Cheonan
Cheonan, , South Korea
St.Mary's Catholic Medical Center
Cheongju-si, , South Korea
Daegu Catholic University Medical Center
Daegu, , South Korea
Keimyung University Dongsan Medical Center
Daegu, , South Korea
Yeungnam University Medical Center
Daegu, , South Korea
Chungnam National University Hospital
Daejeon, , South Korea
The Catholic University of Korea, Daejeon ST.Mary's Hospital
Daejeon, , South Korea
Gangneung Asan Medical Center
Gangneung, , South Korea
Chonnam National University Hospital
Gwangju, , South Korea
National Health Insurance Service Ilsan Hospital
Ilsan, , South Korea
St.Mary's Catholic Medical Center
Inchon, , South Korea
Chonbuk National University Hospital
Jeonju, , South Korea
Presbyterian Medical Center
Jeonju, , South Korea
Kwangju Christian hospital
Kwangju, , South Korea
Pusan Natioanal University Hospital
Pusan, , South Korea
Bundang CHA Hospital
Seongnam, , South Korea
Asan Medical Center
Seoul, , South Korea
Dongguk University Medical Center
Seoul, , South Korea
Gangnam Severance Hospital
Seoul, , South Korea
Kangbuk samsung hospital
Seoul, , South Korea
Kangdong Sacred Heart Hospital
Seoul, , South Korea
Korea University Anam hospital
Seoul, , South Korea
Korea University Guro Hospital
Seoul, , South Korea
Seoul National University Boramae Medical Center
Seoul, , South Korea
Seoul National University Hospital
Seoul, , South Korea
Seoul Veterans Hospital
Seoul, , South Korea
St.Mary's Catholic Medical Center
Seoul, , South Korea
The Catholic University of Korea, ST. Paul's Hospital
Seoul, , South Korea
The Catholic University of Korea, Yeouido ST. Mary's Hospital
Seoul, , South Korea
Yonsei University Medical Center
Seoul, , South Korea
Ajou University Hospital
Suwon, , South Korea
The Catholic University of Korea, ST. Vincent's Hospital
Suwon, , South Korea
Ulsan University Hospital
Ulsan, , South Korea
Wonju Christian Hospital
Wŏnju, , South Korea
Shin Kong Hospital
Taipei, , Taiwan
Siriraj Hospital
Bangkok, , Thailand
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Junbo Ge
Role: primary
K.H. Shim
Role: primary
Woo-jung Park, MD
Role: primary
Tae-hyun Yang, MD
Role: primary
Won Yong Shin
Role: primary
Kee-sik Kim, MD
Role: primary
Seung-ho Hur, MD
Role: primary
Jin-ok Jeong, MD
Role: primary
Sang-sig Cheong, MD
Role: primary
Myung-ho Jeong, MD
Role: primary
Jei-keon Chae, MD
Role: primary
Jay-young Rhew, MD
Role: primary
Seung-uk Lee, MD
Role: primary
June-Hong Kim, MD, PhD
Role: primary
Deuk-young Nah, MD
Role: primary
Hyuck-moon Kwon, MD
Role: primary
Byung-jin Kim, MD
Role: primary
Kyoo-rok Han, MD
Role: primary
Do-sun Lim, MD
Role: primary
Seung-un Na, MD
Role: primary
Woo-young Chung, MD
Role: primary
Hyo-Soo Kim, MD, PhD
Role: primary
Keon-woong Moon, MD
Role: primary
Sang-Gon Lee, MD, PhD
Role: primary
Junghan Yoon
Role: primary
Jun-Jack Cheng
Role: primary
D. Tresukosol
Role: primary
References
Explore related publications, articles, or registry entries linked to this study.
Kim TO, Kang DY, Ahn JM, Kim MJ, Lee PH, Kim H, Choi Y, Lee J, Lee JM, Jo HH, Park YS, Lim SM, Park SJ, Park DW. Impact of Target Lesion Revascularization on Long-Term Mortality After Percutaneous Coronary Intervention for Left Main Disease. JACC Cardiovasc Interv. 2024 Jan 8;17(1):32-42. doi: 10.1016/j.jcin.2023.10.068.
Cho S, Kang DY, Kim JS, Park DW, Kim IS, Kang TS, Ahn JM, Lee PH, Kang SJ, Lee SW, Kim YH, Lee CW, Park SW, Lee SJ, Hong SJ, Ahn CM, Kim BK, Ko YG, Choi D, Jang Y, Hong MK, Park SJ. Dual antiplatelet therapy after percutaneous coronary intervention for left main coronary artery disease. Rev Esp Cardiol (Engl Ed). 2023 Apr;76(4):245-252. doi: 10.1016/j.rec.2022.07.007. Epub 2022 Jul 27. English, Spanish.
Park S, Ahn JM, Park H, Kang DY, Lee PH, Kim TO, Lee J, Kim JH, Yang Y, Jeong YJ, Hyun J, Kim AR, Kim T, Oh HJ, Lee YJ, Lee JH, Jang M, Park DW, Park SJ; IRIS-MAIN Registry Investigators. Comparison of Long-Term Outcomes Following Coronary Revascularization in Men-vs-Women with Unprotected Left Main Disease. Am J Cardiol. 2021 Aug 15;153:9-19. doi: 10.1016/j.amjcard.2021.05.016. Epub 2021 Jul 4.
Park S, Ahn JM, Kim TO, Park H, Kang DY, Lee PH, Jeong YJ, Hyun J, Lee J, Kim JH, Yang Y, Choe K, Park SJ, Park DW; IRIS-MAIN Registry Investigators. Revascularization in Patients With Left Main Coronary Artery Disease and Left Ventricular Dysfunction. J Am Coll Cardiol. 2020 Sep 22;76(12):1395-1406. doi: 10.1016/j.jacc.2020.07.047.
Kang SH, Ahn JM, Lee CH, Lee PH, Kang SJ, Lee SW, Kim YH, Lee CW, Park SW, Park DW, Park SJ. Differential Event Rates and Independent Predictors of Long-Term Major Cardiovascular Events and Death in 5795 Patients With Unprotected Left Main Coronary Artery Disease Treated With Stents, Bypass Surgery, or Medication: Insights From a Large International Multicenter Registry. Circ Cardiovasc Interv. 2017 Jul;10(7):e004988. doi: 10.1161/CIRCINTERVENTIONS.116.004988.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CVRF2010-08
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.